A GHRH analog paired with a ghrelin mimetic. In a Phase 1 trial in healthy adults, a single dose of CJC-1295 raised mean IGF-1 levels 1.5–3x above baseline for 6+ days (Teichman et al., JCEM 2006).
Medical history, current meds, labs if you have them.
If you're not a fit, you don't pay.
503A compounding pharmacy in a temperature-controlled box. Reconstitute, inject subcutaneously at night, log it in the app.
CJC-1295 + Ipamorelin work on the pituitary (GHRH-R and GHS-R1a). Your body still controls the pulse.
Teichman SL et al., J Clin Endocrinol Metab 2006;91(3):799–805. Single-dose, dose-escalation Phase 1 study in 21 healthy men, ages 21–46. Mean serum IGF-1 increased 1.5–3x above baseline depending on
CJC-1295 mimics GHRH and binds the GHRH receptor on your pituitary. Ipamorelin mimics ghrelin and binds GHS-R1a on the same gland. Together they tell the pituitary to release more growth hormone in your body's own natural pulses. Your liver responds by making more IGF-1, which is the downstream signal most adult tissue actually responds to. You are amplifying a system you already have, not bolting on a new one.
Important information about CJC-1295 / Ipamorelin safety and side effects.
No. This is a prescription written by a board-certified U.S. physician and dispensed by a 503A compounding pharmacy. You get a pharmacy label with your name on it, not an unmarked vial from a website.
No peptide on this protocol has FDA approval for anti-aging or recovery. They are legally prescribed off-label, which is how a large share of every category of medicine is prescribed in the U.S.
Yes. The FDA placed CJC-1295 and Ipamorelin on the 503A Category 2 list, which means the agency has flagged them as substances raising significant safety concerns and they are not currently on the official 503A bulks list for compounding. The regulatory status is evolving and the FDA has not finalized its position. Our pharmacy partner continues to compound these peptides under their own legal interpretation of the current rules. Before you start, verify the current FDA status yourself — search "FDA 503A Category 2 bulk drug substances." Know that access could change. If it does, we will tell you in writing the day it does and we will not auto-bill you into a prescription we cannot fill.
Mechanistically, no. CJC-1295 + Ipamorelin push your pituitary to release more of your own GH. Direct rHGH (Genotropin, Norditropin) is the one that suppresses the axis. You should still get IGF-1 checked at baseline and again at 3 months. We order the labs.
No. It is contraindicated. IGF-1 elevation is the reason. If you have a personal history of cancer, the physician decides case by case.
GH can raise fasting glucose. If you're pre-diabetic or diabetic, the physician adjusts the dose or declines the prescription. We re-check fasting glucose and A1c at 3 months.
No retail clinic markup, no in-person visits, one pharmacy partner, subscription pricing. Same molecule, same 503A pharmacy class, fraction of the cost.
Real reviews from verified ArgoMD patients.
Started CJC-1295 / Ipamorelin for recovery after a shoulder injury. Within weeks I noticed reduced pain and faster healing than my PT expected. Impressed.
As someone who trains hard, CJC-1295 / Ipamorelin has been a game changer for recovery. Less soreness, faster return to training, and my joints feel better overall.
My physician at ArgoMD recommended CJC-1295 / Ipamorelin as part of my optimization protocol. The quality is excellent and the results speak for themselves.
Your health and safety are our top priorities.